{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "06",
                "@timestamp": "2022-03-06T09:20:15.000015-05:00",
                "@year": "2022",
                "@month": "03"
            },
            "ait:date-sort": {
                "@day": "01",
                "@year": "2021",
                "@month": "09"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding": [
                {"xocs:funding-agency-matched-string": "Complementary Medicine for Gastrointestinal and Liver Diseases Research Unit"},
                {
                    "xocs:funding-agency-matched-string": "Chulalongkorn University",
                    "xocs:funding-agency-acronym": "CU",
                    "xocs:funding-agency": "Chulalongkorn University",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/501100002873",
                    "xocs:funding-agency-country": "http://sws.geonames.org/1605651/"
                },
                {
                    "xocs:funding-agency-matched-string": "Thailand Research Fund",
                    "xocs:funding-agency-acronym": "TRF",
                    "xocs:funding-agency": "Thailand Research Fund",
                    "xocs:funding-id": "RTA628004",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/501100004396",
                    "xocs:funding-agency-country": "http://sws.geonames.org/1605651/"
                },
                {
                    "xocs:funding-agency-matched-string": "Faculty of Medicine, Chulalongkorn University",
                    "xocs:funding-agency-acronym": "MDCU",
                    "xocs:funding-agency": "Faculty of Medicine, Chulalongkorn University",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/501100004776",
                    "xocs:funding-agency-country": "http://sws.geonames.org/1605651/"
                }
            ],
            "xocs:funding-addon-generated-timestamp": "2021-09-15T23:23:14.069Z",
            "xocs:funding-text": "This study was partially funded by the following funders: Alternative and Complementary Medicine for Gastrointestinal and Liver Diseases Research Unit, Faculty of Medicine, Chulalongkorn University; Center of Excellence in Hepatitis and Liver Cancer, Faculty of Medicine, Chulalongkorn University; and the Thailand Research Fund (TRF), Senior Research Scholar (RTA628004). Financial statement:",
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"
        }},
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60028190",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Alternative and Complementary Medicine for Gastrointestinal and Liver Diseases Research Unit"},
                                {"$": "Department of Physiology"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60028190",
                                "@dptid": "110139558"
                            },
                            "@affiliation-instance-id": "2011155724-2927f3cb5736b7cec134e3c9dab3afe4",
                            "ce:source-text": "Alternative and Complementary Medicine for Gastrointestinal and Liver Diseases Research Unit, Department of Physiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand",
                            "@dptid": "110139558"
                        },
                        "author": [
                            {
                                "ce:given-name": "Aunchalee",
                                "preferred-name": {
                                    "ce:given-name": "Aunchalee",
                                    "ce:initials": "A.",
                                    "ce:surname": "Jaroenlapnopparat",
                                    "ce:indexed-name": "Jaroenlapnopparat A."
                                },
                                "@author-instance-id": "2011155724-9bc960b3bb5aa0b9c143761622e18c07",
                                "@seq": "1",
                                "ce:initials": "A.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Jaroenlapnopparat",
                                "@auid": "57222961052",
                                "ce:indexed-name": "Jaroenlapnopparat A."
                            },
                            {
                                "ce:given-name": "Maneerat",
                                "preferred-name": {
                                    "ce:given-name": "Maneerat",
                                    "ce:initials": "M.",
                                    "ce:surname": "Chayanupatkul",
                                    "ce:indexed-name": "Chayanupatkul M."
                                },
                                "@author-instance-id": "2011155724-999290654f77456475ab8482f63a8b63",
                                "@seq": "2",
                                "ce:initials": "M.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Chayanupatkul",
                                "@auid": "26031971600",
                                "@orcid": "0000-0002-1649-5373",
                                "ce:indexed-name": "Chayanupatkul M."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60028190",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Center of Excellence in Hepatitis and Liver Cancer"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60028190",
                                "@dptid": "113742843"
                            },
                            "@affiliation-instance-id": "2011155724-97a5e52d025893f14c583b20c1229777",
                            "ce:source-text": "Center of Excellence in Hepatitis and Liver Cancer, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand",
                            "@dptid": "113742843"
                        },
                        "author": [{
                            "ce:given-name": "Pisit",
                            "preferred-name": {
                                "ce:given-name": "Pisit",
                                "ce:initials": "P.",
                                "ce:surname": "Tangkijvanich",
                                "ce:indexed-name": "Tangkijvanich P."
                            },
                            "@author-instance-id": "2011155724-d31652a0d91a3cfe197001c1e009cc4b",
                            "@seq": "3",
                            "ce:initials": "P.",
                            "@date-locked": "2022-01-31T12:27:27.966",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Tangkijvanich",
                            "@auid": "7003646635",
                            "ce:indexed-name": "Tangkijvanich P."
                        }]
                    }
                ],
                "citation-title": "Novel viral markers and the prediction of off-treatment relapse in chronic hepatitis B patients: A systematic review",
                "abstracts": "© 2021 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, LtdBackground and Aim: Hepatitis B core-related antigen (HBcrAg) and hepatitis B virus RNA (HBV RNA) are novel markers that reflect intrahepatic cccDNA and could be useful in the prediction of relapse after nucleos(t)ide analogues (NA) discontinuation. The aim of the study is to perform a systematic review on this issue. Methods: Medline/Pubmed database was searched using text terms related to HBcrAg, RNA, NAs, discontinuation, and relapse. Included studies were those that enrolled adult patients who had been on NAs for more than 6 months with available information on end-of-treatment (EOT) HBcrAg and/or HBV RNA and relapse rates. Results: Sixteen studies were included. Virological and clinical relapse rates ranged from 11% to 100% and 11% to 73%, respectively. Low or undetectable EOT HBcrAg levels were associated with low off-treatment relapse rates in most studies with area under the receiver operating characteristic curve (AUROC) of 0.69\u20130.70 for predicting virological relapse (VR) and 0.61\u20130.77 for predicting clinical relapse (CR). Undetectable EOT HBV RNA was associated with a lower risk of off-treatment relapse with AUROC of 0.65\u20130.76 for predicting VR and 0.66\u20130.73 for predicting CR. Combined EOT HBcrAg and HBV RNA performed better in predicting off-treatment relapse than either test alone with AUROC of 0.816\u20130.846 for predicting CR. None of the patients with double-negative HBV RNA and HBcrAg developed CR. Conclusion: Combining HBcrAg with HBV RNA or HBsAg improved the discriminating abilities in the prediction of off-treatment relapse of each test. Patients with double-negative HBcrAg and HBV RNA at EOT had low risks of relapse and could be considered for NA discontinuation.",
                "correspondence": {
                    "affiliation": {
                        "country": "Thailand",
                        "@country": "tha",
                        "city": "Bangkok",
                        "organization": [
                            {"$": "Alternative and Complementary Medicine for Gastrointestinal and Liver Diseases Research Unit"},
                            {"$": "Department of Physiology"},
                            {"$": "Faculty of Medicine"},
                            {"$": "Chulalongkorn University"}
                        ],
                        "ce:source-text": "Alternative and Complementary Medicine for Gastrointestinal and Liver Diseases Research Unit, Department of Physiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand"
                    },
                    "person": {
                        "ce:given-name": "Maneerat",
                        "ce:initials": "M.",
                        "ce:surname": "Chayanupatkul",
                        "ce:indexed-name": "Chayanupatkul M."
                    }
                },
                "citation-info": {
                    "author-keywords": {"author-keyword": [
                        {
                            "$": "Chronic hepatitis B",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Hepatitis B core-related antigen",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Hepatitis B virus RNA",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Nucleos(t)ide analogues",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Relapse",
                            "@xml:lang": "eng",
                            "@original": "y"
                        }
                    ]},
                    "citation-type": {"@code": "ar"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "website": {"ce:e-address": {
                        "$": "http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1440-1746",
                        "@type": "email"
                    }},
                    "translated-sourcetitle": {
                        "$": "Journal of Gastroenterology and Hepatology",
                        "@xml:lang": "eng"
                    },
                    "volisspag": {
                        "voliss": {
                            "@volume": "36",
                            "@issue": "9"
                        },
                        "pagerange": {
                            "@first": "2349",
                            "@last": "2362"
                        }
                    },
                    "@type": "j",
                    "sourcetitle": "Journal of Gastroenterology and Hepatology (Australia)",
                    "publicationdate": {
                        "month": "09",
                        "year": "2021",
                        "date-text": "September 2021",
                        "day": "01"
                    },
                    "codencode": "JGHEE",
                    "sourcetitle-abbrev": "J. Gastroenterol. Hepatol.",
                    "@country": "aus",
                    "issn": [
                        {
                            "$": "14401746",
                            "@type": "electronic"
                        },
                        {
                            "$": "08159319",
                            "@type": "print"
                        }
                    ],
                    "publicationyear": {"@first": "2021"},
                    "publisher": {"publishername": "John Wiley and Sons Inc"},
                    "@srcid": "25296"
                },
                "enhancement": {
                    "classificationgroup": {"classifications": [
                        {
                            "@type": "CABSCLASS",
                            "classification": {
                                "classification-code": "99",
                                "classification-description": "General"
                            }
                        },
                        {
                            "@type": "EMCLASS",
                            "classification": [
                                {
                                    "classification-code": "37",
                                    "classification-description": "Drug Literature Index"
                                },
                                {
                                    "classification-code": "48",
                                    "classification-description": "Gastroenterology"
                                },
                                {
                                    "classification-code": "6",
                                    "classification-description": "Internal Medicine"
                                }
                            ]
                        },
                        {
                            "@type": "ASJC",
                            "classification": [
                                {"$": "2721"},
                                {"$": "2715"}
                            ]
                        },
                        {
                            "@type": "SUBJABBR",
                            "classification": "MEDI"
                        }
                    ]},
                    "chemicalgroup": {"chemicals": [
                        {
                            "@source": "esbd",
                            "chemical": [
                                {
                                    "cas-registry-number": [
                                        {"$": "9000-86-6"},
                                        {"$": "9014-30-6"}
                                    ],
                                    "enzyme-commission-number": "EC 2.6.1.2",
                                    "chemical-name": "alanine aminotransferase"
                                },
                                {
                                    "cas-registry-number": [
                                        {"$": "142217-69-4"},
                                        {"$": "209216-23-9"}
                                    ],
                                    "chemical-name": "entecavir"
                                },
                                {
                                    "cas-registry-number": [
                                        {"$": "134678-17-4"},
                                        {"$": "134680-32-3"}
                                    ],
                                    "chemical-name": "lamivudine"
                                },
                                {
                                    "cas-registry-number": "3424-98-4",
                                    "chemical-name": "telbivudine"
                                },
                                {
                                    "cas-registry-number": [
                                        {"$": "147127-19-3"},
                                        {"$": "147127-20-6"}
                                    ],
                                    "chemical-name": "tenofovir"
                                }
                            ]
                        },
                        {
                            "@source": "nlm",
                            "chemical": [
                                {"chemical-name": "Biomarkers"},
                                {"chemical-name": "Hepatitis B Core Antigens"},
                                {"chemical-name": "RNA, Viral"}
                            ]
                        }
                    ]}
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2021 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "external-source": "In-Process",
                "dbcollection": [
                    {"$": "CABS"},
                    {"$": "EMBASE"},
                    {"$": "MEDL"},
                    {"$": "PHARMAPENDIUM"},
                    {"$": "REAXYSCAR"},
                    {"$": "SCOPUS"},
                    {"$": "Scopusbase"}
                ],
                "history": {"date-created": {
                    "@day": "19",
                    "@timestamp": "BST 03:35:33",
                    "@year": "2021",
                    "@month": "10"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "2011155724",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "634733166",
                            "@idtype": "associatedPUI"
                        },
                        {
                            "$": "2021168608",
                            "@idtype": "CABS"
                        },
                        {
                            "$": "932563220",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "20210374386",
                            "@idtype": "EMBASE"
                        },
                        {
                            "$": "33811375",
                            "@idtype": "MEDL"
                        },
                        {
                            "$": "55746",
                            "@idtype": "PHARMAPENDIUM"
                        },
                        {
                            "$": "20211639411",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "20211280982",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "20210020232978",
                            "@idtype": "TPA-ID"
                        },
                        {
                            "$": "85104272028",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85104272028",
                            "@idtype": "SGR"
                        },
                        {
                            "$": "634733166",
                            "@idtype": "PUIsecondary"
                        },
                        {
                            "$": "76730999",
                            "@idtype": "OSIN"
                        }
                    ],
                    "ce:doi": "10.1111/jgh.15516"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "42",
                "reference": [
                    {
                        "ref-fulltext": "WHO. Global Hepatitis Report 2017. cited 01/06/2020. Available from: https://apps.who.int/iris/rest/bitstreams/1082592/retrieve",
                        "@id": "1",
                        "ref-info": {
                            "ref-website": {"ce:e-address": {
                                "$": "https://apps.who.int/iris/rest/bitstreams/1082592/retrieve",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "jgh15516-cit-0002",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85041488806",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "cited 01/06/2020. Available from",
                            "ref-authors": {"collaboration": {
                                "@seq": "1",
                                "ce:text": "WHO",
                                "ce:indexed-name": "WHO"
                            }},
                            "ref-sourcetitle": "Global Hepatitis Report 2017"
                        },
                        "ce:source-text": "WHO. Global Hepatitis Report 2017. cited 01/06/2020. Available from: https://apps.who.int/iris/rest/bitstreams/1082592/retrieve"
                    },
                    {
                        "ref-fulltext": "Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet 2015; 386: 1546\u20131555.",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "jgh15516-cit-0003",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84947346338",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "386"},
                                "pagerange": {
                                    "@first": "1546",
                                    "@last": "1555"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Schweitzer",
                                    "ce:indexed-name": "Schweitzer A."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Horn",
                                    "ce:indexed-name": "Horn J."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "R.T.",
                                    "@_fa": "true",
                                    "ce:surname": "Mikolajczyk",
                                    "ce:indexed-name": "Mikolajczyk R.T."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "G.",
                                    "@_fa": "true",
                                    "ce:surname": "Krause",
                                    "ce:indexed-name": "Krause G."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "J.J.",
                                    "@_fa": "true",
                                    "ce:surname": "Ott",
                                    "ce:indexed-name": "Ott J.J."
                                }
                            ]},
                            "ref-sourcetitle": "Lancet"
                        },
                        "ce:source-text": "Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet 2015; 386: 1546\u20131555."
                    },
                    {
                        "ref-fulltext": "Honda K, Seike M, Murakami K. Benefits of nucleos(t)ide analog treatments for hepatitis B virus-related cirrhosis. World. J. Hepatol. 2015; 7: 2404\u20132410.",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Benefits of nucleos(t)ide analog treatments for hepatitis B virus-related cirrhosis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "jgh15516-cit-0004",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84943421085",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "7"},
                                "pagerange": {
                                    "@first": "2404",
                                    "@last": "2410"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "K.",
                                    "@_fa": "true",
                                    "ce:surname": "Honda",
                                    "ce:indexed-name": "Honda K."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Seike",
                                    "ce:indexed-name": "Seike M."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "K.",
                                    "@_fa": "true",
                                    "ce:surname": "Murakami",
                                    "ce:indexed-name": "Murakami K."
                                }
                            ]},
                            "ref-sourcetitle": "World. J. Hepatol."
                        },
                        "ce:source-text": "Honda K, Seike M, Murakami K. Benefits of nucleos(t)ide analog treatments for hepatitis B virus-related cirrhosis. World. J. Hepatol. 2015; 7: 2404\u20132410."
                    },
                    {
                        "ref-fulltext": "Hou J-L, Zhao W, Lee C et al. Outcomes of long-term treatment of chronic HBV infection with entecavir or other agents from a randomized trial in 24 countries. Clin. Gastroenterol. Hepatol. 2020; 18: 457\u2013467.",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Outcomes of long-term treatment of chronic HBV infection with entecavir or other agents from a randomized trial in 24 countries"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "jgh15516-cit-0005",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85077656136",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "18"},
                                "pagerange": {
                                    "@first": "457",
                                    "@last": "467"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.-L.",
                                        "@_fa": "true",
                                        "ce:surname": "Hou",
                                        "ce:indexed-name": "Hou J.-L."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "W.",
                                        "@_fa": "true",
                                        "ce:surname": "Zhao",
                                        "ce:indexed-name": "Zhao W."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Lee",
                                        "ce:indexed-name": "Lee C."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin. Gastroenterol. Hepatol."
                        },
                        "ce:source-text": "Hou J-L, Zhao W, Lee C et al. Outcomes of long-term treatment of chronic HBV infection with entecavir or other agents from a randomized trial in 24 countries. Clin. Gastroenterol. Hepatol. 2020; 18: 457\u2013467."
                    },
                    {
                        "ref-fulltext": "Zoutendijk R, Hansen BE, van Vuuren AJ, Boucher CA, Janssen HL. Serum HBsAg decline during long-term potent nucleos(t)ide analogue therapy for chronic hepatitis B and prediction of HBsAg loss. J. Infect. Dis. 2011; 204: 415\u2013418.",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Serum HBsAg decline during long-term potent nucleos(t)ide analogue therapy for chronic hepatitis B and prediction of HBsAg loss"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "jgh15516-cit-0006",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "79960124298",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "204"},
                                "pagerange": {
                                    "@first": "415",
                                    "@last": "418"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Zoutendijk",
                                    "ce:indexed-name": "Zoutendijk R."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "B.E.",
                                    "@_fa": "true",
                                    "ce:surname": "Hansen",
                                    "ce:indexed-name": "Hansen B.E."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "A.J.",
                                    "@_fa": "true",
                                    "ce:surname": "van Vuuren",
                                    "ce:indexed-name": "van Vuuren A.J."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "C.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Boucher",
                                    "ce:indexed-name": "Boucher C.A."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "H.L.",
                                    "@_fa": "true",
                                    "ce:surname": "Janssen",
                                    "ce:indexed-name": "Janssen H.L."
                                }
                            ]},
                            "ref-sourcetitle": "J. Infect. Dis."
                        },
                        "ce:source-text": "Zoutendijk R, Hansen BE, van Vuuren AJ, Boucher CA, Janssen HL. Serum HBsAg decline during long-term potent nucleos(t)ide analogue therapy for chronic hepatitis B and prediction of HBsAg loss. J. Infect. Dis. 2011; 204: 415\u2013418."
                    },
                    {
                        "ref-fulltext": "Chevaliez S, Hézode C, Bahrami S, Grare M, Pawlotsky JM. Long-term hepatitis B surface antigen (HBsAg) kinetics during nucleoside/nucleotide analogue therapy: finite treatment duration unlikely. J. Hepatol. 2013; 58: 676\u2013683.",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Long-term hepatitis B surface antigen (HBsAg) kinetics during nucleoside/nucleotide analogue therapy: finite treatment duration unlikely"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "jgh15516-cit-0007",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84880939335",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "58"},
                                "pagerange": {
                                    "@first": "676",
                                    "@last": "683"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Chevaliez",
                                    "ce:indexed-name": "Chevaliez S."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "Hézode",
                                    "ce:indexed-name": "Hezode C."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Bahrami",
                                    "ce:indexed-name": "Bahrami S."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Grare",
                                    "ce:indexed-name": "Grare M."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "J.M.",
                                    "@_fa": "true",
                                    "ce:surname": "Pawlotsky",
                                    "ce:indexed-name": "Pawlotsky J.M."
                                }
                            ]},
                            "ref-sourcetitle": "J. Hepatol."
                        },
                        "ce:source-text": "Chevaliez S, Hézode C, Bahrami S, Grare M, Pawlotsky JM. Long-term hepatitis B surface antigen (HBsAg) kinetics during nucleoside/nucleotide analogue therapy: finite treatment duration unlikely. J. Hepatol. 2013; 58: 676\u2013683."
                    },
                    {
                        "ref-fulltext": "EASL. 2017 clinical practice guidelines on the management of hepatitis B virus infection. J. Hepatol. 2017; 67: 370\u2013398.",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "2017 clinical practice guidelines on the management of hepatitis B virus infection"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "jgh15516-cit-0008",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85017533115",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "67"},
                                "pagerange": {
                                    "@first": "370",
                                    "@last": "398"
                                }
                            },
                            "ref-authors": {"collaboration": {
                                "@seq": "1",
                                "ce:text": "EASL",
                                "ce:indexed-name": "EASL"
                            }},
                            "ref-sourcetitle": "J. Hepatol."
                        },
                        "ce:source-text": "EASL. 2017 clinical practice guidelines on the management of hepatitis B virus infection. J. Hepatol. 2017; 67: 370\u2013398."
                    },
                    {
                        "ref-fulltext": "Sarin SK, Kumar M, Lau GK et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol. Int. 2016; 10: 1\u201398.",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "jgh15516-cit-0009",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84984562922",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "10"},
                                "pagerange": {
                                    "@first": "1",
                                    "@last": "98"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.K.",
                                        "@_fa": "true",
                                        "ce:surname": "Sarin",
                                        "ce:indexed-name": "Sarin S.K."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Kumar",
                                        "ce:indexed-name": "Kumar M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "G.K.",
                                        "@_fa": "true",
                                        "ce:surname": "Lau",
                                        "ce:indexed-name": "Lau G.K."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Hepatol. Int."
                        },
                        "ce:source-text": "Sarin SK, Kumar M, Lau GK et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol. Int. 2016; 10: 1\u201398."
                    },
                    {
                        "ref-fulltext": "Terrault NA, Lok ASF, McMahon BJ et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology 2018; 67: 1560\u20131599.",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "jgh15516-cit-0010",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85044252801",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "67"},
                                "pagerange": {
                                    "@first": "1560",
                                    "@last": "1599"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "N.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Terrault",
                                        "ce:indexed-name": "Terrault N.A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.S.F.",
                                        "@_fa": "true",
                                        "ce:surname": "Lok",
                                        "ce:indexed-name": "Lok A.S.F."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "B.J.",
                                        "@_fa": "true",
                                        "ce:surname": "McMahon",
                                        "ce:indexed-name": "McMahon B.J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Hepatology"
                        },
                        "ce:source-text": "Terrault NA, Lok ASF, McMahon BJ et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology 2018; 67: 1560\u20131599."
                    },
                    {
                        "ref-fulltext": "Kranidioti HMS, Khakoo SI. Outcome after discontinuation of nucleot(s)ide analogues in chronic hepatitis B: relapse rate and associated factors. Ann. Gastroenterol. 2015; 28: 173\u2013181.",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Outcome after discontinuation of nucleot(s)ide analogues in chronic hepatitis B: relapse rate and associated factors"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "jgh15516-cit-0011",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84926336363",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "28"},
                                "pagerange": {
                                    "@first": "173",
                                    "@last": "181"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "H.M.S.",
                                    "@_fa": "true",
                                    "ce:surname": "Kranidioti",
                                    "ce:indexed-name": "Kranidioti H.M.S."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.I.",
                                    "@_fa": "true",
                                    "ce:surname": "Khakoo",
                                    "ce:indexed-name": "Khakoo S.I."
                                }
                            ]},
                            "ref-sourcetitle": "Ann. Gastroenterol."
                        },
                        "ce:source-text": "Kranidioti HMS, Khakoo SI. Outcome after discontinuation of nucleot(s)ide analogues in chronic hepatitis B: relapse rate and associated factors. Ann. Gastroenterol. 2015; 28: 173\u2013181."
                    },
                    {
                        "ref-fulltext": "Papatheodoridis G, Vlachogiannakos I, Cholongitas E et al. Discontinuation of oral antivirals in chronic hepatitis B: a systematic review. Hepatology 2016; 63: 1481\u20131492.",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Discontinuation of oral antivirals in chronic hepatitis B: a systematic review"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "jgh15516-cit-0012",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84959470623",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "63"},
                                "pagerange": {
                                    "@first": "1481",
                                    "@last": "1492"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "G.",
                                        "@_fa": "true",
                                        "ce:surname": "Papatheodoridis",
                                        "ce:indexed-name": "Papatheodoridis G."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "I.",
                                        "@_fa": "true",
                                        "ce:surname": "Vlachogiannakos",
                                        "ce:indexed-name": "Vlachogiannakos I."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Cholongitas",
                                        "ce:indexed-name": "Cholongitas E."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Hepatology"
                        },
                        "ce:source-text": "Papatheodoridis G, Vlachogiannakos I, Cholongitas E et al. Discontinuation of oral antivirals in chronic hepatitis B: a systematic review. Hepatology 2016; 63: 1481\u20131492."
                    },
                    {
                        "ref-fulltext": "Liu J, Li T, Zhang L, Xu A. The role of hepatitis B surface antigen in nucleos(t)ide analogues cessation among Asian patients with chronic hepatitis B: a systematic review. Hepatology 2019; 70: 1045\u20131055.",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "The role of hepatitis B surface antigen in nucleos(t)ide analogues cessation among Asian patients with chronic hepatitis B: a systematic review"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "jgh15516-cit-0013",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85071489756",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "70"},
                                "pagerange": {
                                    "@first": "1045",
                                    "@last": "1055"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Liu",
                                    "ce:indexed-name": "Liu J."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "T.",
                                    "@_fa": "true",
                                    "ce:surname": "Li",
                                    "ce:indexed-name": "Li T."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "L.",
                                    "@_fa": "true",
                                    "ce:surname": "Zhang",
                                    "ce:indexed-name": "Zhang L."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Xu",
                                    "ce:indexed-name": "Xu A."
                                }
                            ]},
                            "ref-sourcetitle": "Hepatology"
                        },
                        "ce:source-text": "Liu J, Li T, Zhang L, Xu A. The role of hepatitis B surface antigen in nucleos(t)ide analogues cessation among Asian patients with chronic hepatitis B: a systematic review. Hepatology 2019; 70: 1045\u20131055."
                    },
                    {
                        "ref-fulltext": "Chen EQ, Wang ML, Tao YC et al. Serum HBcrAg is better than HBV RNA and HBsAg in reflecting intrahepatic covalently closed circular DNA. J. Viral. Hepat. 2019; 26: 586\u2013595.",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Serum HBcrAg is better than HBV RNA and HBsAg in reflecting intrahepatic covalently closed circular DNA"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "jgh15516-cit-0014",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85060870555",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "26"},
                                "pagerange": {
                                    "@first": "586",
                                    "@last": "595"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "E.Q.",
                                        "@_fa": "true",
                                        "ce:surname": "Chen",
                                        "ce:indexed-name": "Chen E.Q."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Wang",
                                        "ce:indexed-name": "Wang M.L."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "Y.C.",
                                        "@_fa": "true",
                                        "ce:surname": "Tao",
                                        "ce:indexed-name": "Tao Y.C."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Viral. Hepat."
                        },
                        "ce:source-text": "Chen EQ, Wang ML, Tao YC et al. Serum HBcrAg is better than HBV RNA and HBsAg in reflecting intrahepatic covalently closed circular DNA. J. Viral. Hepat. 2019; 26: 586\u2013595."
                    },
                    {
                        "ref-fulltext": "Mak LY, Wong DK, Cheung KS, Seto WK, Lai CL, Yuen MF. Review article: hepatitis B core-related antigen (HBcrAg): an emerging marker for chronic hepatitis B virus infection. Aliment. Pharmacol. Ther. 2018; 47: 43\u201354.",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Review article: hepatitis B core-related antigen (HBcrAg): an emerging marker for chronic hepatitis B virus infection"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "jgh15516-cit-0015",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85031503325",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "47"},
                                "pagerange": {
                                    "@first": "43",
                                    "@last": "54"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "L.Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Mak",
                                    "ce:indexed-name": "Mak L.Y."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "D.K.",
                                    "@_fa": "true",
                                    "ce:surname": "Wong",
                                    "ce:indexed-name": "Wong D.K."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "K.S.",
                                    "@_fa": "true",
                                    "ce:surname": "Cheung",
                                    "ce:indexed-name": "Cheung K.S."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "W.K.",
                                    "@_fa": "true",
                                    "ce:surname": "Seto",
                                    "ce:indexed-name": "Seto W.K."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "C.L.",
                                    "@_fa": "true",
                                    "ce:surname": "Lai",
                                    "ce:indexed-name": "Lai C.L."
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "M.F.",
                                    "@_fa": "true",
                                    "ce:surname": "Yuen",
                                    "ce:indexed-name": "Yuen M.F."
                                }
                            ]},
                            "ref-sourcetitle": "Aliment. Pharmacol. Ther."
                        },
                        "ce:source-text": "Mak LY, Wong DK, Cheung KS, Seto WK, Lai CL, Yuen MF. Review article: hepatitis B core-related antigen (HBcrAg): an emerging marker for chronic hepatitis B virus infection. Aliment. Pharmacol. Ther. 2018; 47: 43\u201354."
                    },
                    {
                        "ref-fulltext": "Cloherty G, Butler E, Kuhns M. Serum hepatitis B virus RNA as a potential diagnostic biomarker during chronic hepatitis B virus infection. Clin. Liver. Dis. 2019; 13: 90\u201392.",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Serum hepatitis B virus RNA as a potential diagnostic biomarker during chronic hepatitis B virus infection"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "jgh15516-cit-0016",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85063578485",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "13"},
                                "pagerange": {
                                    "@first": "90",
                                    "@last": "92"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "G.",
                                    "@_fa": "true",
                                    "ce:surname": "Cloherty",
                                    "ce:indexed-name": "Cloherty G."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "E.",
                                    "@_fa": "true",
                                    "ce:surname": "Butler",
                                    "ce:indexed-name": "Butler E."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Kuhns",
                                    "ce:indexed-name": "Kuhns M."
                                }
                            ]},
                            "ref-sourcetitle": "Clin. Liver. Dis."
                        },
                        "ce:source-text": "Cloherty G, Butler E, Kuhns M. Serum hepatitis B virus RNA as a potential diagnostic biomarker during chronic hepatitis B virus infection. Clin. Liver. Dis. 2019; 13: 90\u201392."
                    },
                    {
                        "ref-fulltext": "Allweiss LDM. The role of cccDNA in HBV maintenance. Viruses. 2017; 9: 156. Cited 01/06/2020. Available from URL https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5490831/",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5490831/",
                                "@type": "email"
                            }},
                            "ref-title": {"ref-titletext": "The role of cccDNA in HBV maintenance"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "jgh15516-cit-0017",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85021637153",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "9"},
                                "pagerange": {"@first": "156"}
                            },
                            "ref-text": "Cited 01/06/2020. Available from URL",
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "L.D.M.",
                                "@_fa": "true",
                                "ce:surname": "Allweiss",
                                "ce:indexed-name": "Allweiss L.D.M."
                            }]},
                            "ref-sourcetitle": "Viruses."
                        },
                        "ce:source-text": "Allweiss LDM. The role of cccDNA in HBV maintenance. Viruses. 2017; 9: 156. Cited 01/06/2020. Available from URL https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5490831/"
                    },
                    {
                        "ref-fulltext": "Lin Wang XC, Wang Z, Gao Y, Deng J, Liu X, Zhuang H. Correlation of HBcrAg with Intrahepatic Hepatitis B Virus Total DNA and Covalently Closed Circular DNA in HBeAg-Positive Chronic Hepatitis B Patients. J. Clin. Microbiol. 2019; 57: e01303. https://doi.org/10.1128/JCM.01303-18",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://doi.org/10.1128/JCM.01303-18",
                                "@type": "email"
                            }},
                            "ref-title": {"ref-titletext": "Correlation of HBcrAg with Intrahepatic Hepatitis B Virus Total DNA and Covalently Closed Circular DNA in HBeAg-Positive Chronic Hepatitis B Patients"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "jgh15516-cit-0018",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85059425896",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {"@volume": "57"}},
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "X.C.",
                                    "@_fa": "true",
                                    "ce:surname": "Lin Wang",
                                    "ce:indexed-name": "Lin Wang X.C."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "Z.",
                                    "@_fa": "true",
                                    "ce:surname": "Wang",
                                    "ce:indexed-name": "Wang Z."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Gao",
                                    "ce:indexed-name": "Gao Y."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Deng",
                                    "ce:indexed-name": "Deng J."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "X.",
                                    "@_fa": "true",
                                    "ce:surname": "Liu",
                                    "ce:indexed-name": "Liu X."
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "H.",
                                    "@_fa": "true",
                                    "ce:surname": "Zhuang",
                                    "ce:indexed-name": "Zhuang H."
                                }
                            ]},
                            "ref-sourcetitle": "J. Clin. Microbiol."
                        },
                        "ce:source-text": "Lin Wang XC, Wang Z, Gao Y, Deng J, Liu X, Zhuang H. Correlation of HBcrAg with Intrahepatic Hepatitis B Virus Total DNA and Covalently Closed Circular DNA in HBeAg-Positive Chronic Hepatitis B Patients. J. Clin. Microbiol. 2019; 57: e01303. https://doi.org/10.1128/JCM.01303-18"
                    },
                    {
                        "ref-fulltext": "Matsumoto A, Tanaka E, Minami M et al. Low serum level of hepatitis B core-related antigen indicates unlikely reactivation of hepatitis after cessation of lamivudine therapy. Hepatol. Res. 2007; 37: 661\u2013666.",
                        "@id": "18",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-title": {"ref-titletext": "Low serum level of hepatitis B core-related antigen indicates unlikely reactivation of hepatitis after cessation of lamivudine therapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "jgh15516-cit-0019",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "34347327086",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "37"},
                                "pagerange": {
                                    "@first": "661",
                                    "@last": "666"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Matsumoto",
                                        "ce:indexed-name": "Matsumoto A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Tanaka",
                                        "ce:indexed-name": "Tanaka E."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Minami",
                                        "ce:indexed-name": "Minami M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Hepatol. Res."
                        },
                        "ce:source-text": "Matsumoto A, Tanaka E, Minami M et al. Low serum level of hepatitis B core-related antigen indicates unlikely reactivation of hepatitis after cessation of lamivudine therapy. Hepatol. Res. 2007; 37: 661\u2013666."
                    },
                    {
                        "ref-fulltext": "JSH Guidelines for the Management of Hepatitis B Virus Infection. Hepatol. Res. 2014; 44: 1\u201358.",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "JSH Guidelines for the Management of Hepatitis B Virus Infection"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "jgh15516-cit-0020",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84891907570",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "44"},
                                "pagerange": {
                                    "@first": "1",
                                    "@last": "58"
                                }
                            },
                            "ref-sourcetitle": "Hepatol. Res."
                        },
                        "ce:source-text": "JSH Guidelines for the Management of Hepatitis B Virus Infection. Hepatol. Res. 2014; 44: 1\u201358."
                    },
                    {
                        "ref-fulltext": "Sonneveld MJ, Park JY, Kaewdech A et al. Prediction of sustained response after nucleo(s)tide analogue cessation using Hbsag and Hbcrag levels\u2014a multicenter study (CREATE). Clin. Gastroenterol. Hepatol. 2020. https://doi.org/10.1016/j.cgh.2020.12.005",
                        "@id": "20",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://doi.org/10.1016/j.cgh.2020.12.005",
                                "@type": "email"
                            }},
                            "ref-title": {"ref-titletext": "Prediction of sustained response after nucleo(s)tide analogue cessation using Hbsag and Hbcrag levels\u2014a multicenter study (CREATE)"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "jgh15516-cit-0021",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85104274872",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Sonneveld",
                                        "ce:indexed-name": "Sonneveld M.J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Park",
                                        "ce:indexed-name": "Park J.Y."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Kaewdech",
                                        "ce:indexed-name": "Kaewdech A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin. Gastroenterol. Hepatol."
                        },
                        "ce:source-text": "Sonneveld MJ, Park JY, Kaewdech A et al. Prediction of sustained response after nucleo(s)tide analogue cessation using Hbsag and Hbcrag levels\u2014a multicenter study (CREATE). Clin. Gastroenterol. Hepatol. 2020. https://doi.org/10.1016/j.cgh.2020.12.005"
                    },
                    {
                        "ref-fulltext": "Seto WK, Liu KS, Mak LY et al. Role of serum HBV RNA and hepatitis B surface antigen levels in identifying Asian patients with chronic hepatitis B suitable for entecavir cessation. Gut 2020. https://doi.org/10.1136/gutjnl-2020-321116",
                        "@id": "21",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://doi.org/10.1136/gutjnl-2020-321116",
                                "@type": "email"
                            }},
                            "ref-title": {"ref-titletext": "Role of serum HBV RNA and hepatitis B surface antigen levels in identifying Asian patients with chronic hepatitis B suitable for entecavir cessation"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "jgh15516-cit-0022",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85096007278",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "W.K.",
                                        "@_fa": "true",
                                        "ce:surname": "Seto",
                                        "ce:indexed-name": "Seto W.K."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "K.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Liu",
                                        "ce:indexed-name": "Liu K.S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "L.Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Mak",
                                        "ce:indexed-name": "Mak L.Y."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Gut"
                        },
                        "ce:source-text": "Seto WK, Liu KS, Mak LY et al. Role of serum HBV RNA and hepatitis B surface antigen levels in identifying Asian patients with chronic hepatitis B suitable for entecavir cessation. Gut 2020. https://doi.org/10.1136/gutjnl-2020-321116"
                    },
                    {
                        "ref-fulltext": "Kaewdech A, Tangkijvanich P, Sripongpun P et al. Hepatitis B surface antigen, core-related antigen, and HBV RNA: predicting clinical relapse after NA therapy discontinuation. Liver. Int. 2020; 40: 2961\u20132971.",
                        "@id": "22",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Hepatitis B surface antigen, core-related antigen, and HBV RNA: predicting clinical relapse after NA therapy discontinuation"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "jgh15516-cit-0023",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85088869258",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "40"},
                                "pagerange": {
                                    "@first": "2961",
                                    "@last": "2971"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Kaewdech",
                                        "ce:indexed-name": "Kaewdech A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Tangkijvanich",
                                        "ce:indexed-name": "Tangkijvanich P."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Sripongpun",
                                        "ce:indexed-name": "Sripongpun P."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Liver. Int."
                        },
                        "ce:source-text": "Kaewdech A, Tangkijvanich P, Sripongpun P et al. Hepatitis B surface antigen, core-related antigen, and HBV RNA: predicting clinical relapse after NA therapy discontinuation. Liver. Int. 2020; 40: 2961\u20132971."
                    },
                    {
                        "ref-fulltext": "Liu Y, Xue J, Liao W, Yan H, Liang X. Serum HBV RNA dynamic and drug withdrawal predictor value in patients with chronic HBV infection on long-term nucleos(t)ide analogue (NA) therapy. J. Clin. Gastroenterol. 2020; 54: e73\u2013e82.",
                        "@id": "23",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Serum HBV RNA dynamic and drug withdrawal predictor value in patients with chronic HBV infection on long-term nucleos(t)ide analogue (NA) therapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "jgh15516-cit-0024",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85089358827",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "54"},
                                "pagerange": {
                                    "@first": "e73",
                                    "@last": "e82"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Liu",
                                    "ce:indexed-name": "Liu Y."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Xue",
                                    "ce:indexed-name": "Xue J."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "W.",
                                    "@_fa": "true",
                                    "ce:surname": "Liao",
                                    "ce:indexed-name": "Liao W."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "H.",
                                    "@_fa": "true",
                                    "ce:surname": "Yan",
                                    "ce:indexed-name": "Yan H."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "X.",
                                    "@_fa": "true",
                                    "ce:surname": "Liang",
                                    "ce:indexed-name": "Liang X."
                                }
                            ]},
                            "ref-sourcetitle": "J. Clin. Gastroenterol."
                        },
                        "ce:source-text": "Liu Y, Xue J, Liao W, Yan H, Liang X. Serum HBV RNA dynamic and drug withdrawal predictor value in patients with chronic HBV infection on long-term nucleos(t)ide analogue (NA) therapy. J. Clin. Gastroenterol. 2020; 54: e73\u2013e82."
                    },
                    {
                        "ref-fulltext": "Fan R, Zhou B, Xu M et al. Association between negative results from tests for HBV DNA and RNA and durability of response after discontinuation of nucles(t)ide analogue therapy. Clin. Gastroenterol. Hepatol. 2020; 18: 719\u2013727.",
                        "@id": "24",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Association between negative results from tests for HBV DNA and RNA and durability of response after discontinuation of nucles(t)ide analogue therapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "jgh15516-cit-0025",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85079246254",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "18"},
                                "pagerange": {
                                    "@first": "719",
                                    "@last": "727"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Fan",
                                        "ce:indexed-name": "Fan R."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "B.",
                                        "@_fa": "true",
                                        "ce:surname": "Zhou",
                                        "ce:indexed-name": "Zhou B."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Xu",
                                        "ce:indexed-name": "Xu M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin. Gastroenterol. Hepatol."
                        },
                        "ce:source-text": "Fan R, Zhou B, Xu M et al. Association between negative results from tests for HBV DNA and RNA and durability of response after discontinuation of nucles(t)ide analogue therapy. Clin. Gastroenterol. Hepatol. 2020; 18: 719\u2013727."
                    },
                    {
                        "ref-fulltext": "Fan R, Peng J, Xie Q et al. Combining HBV RNA and hepatitis B core-related antigen: guidance for safely stopping nucleos(t)ide analogues in HBeAg-positive chronic hepatitis B patients. J. Infect. Dis. 2020; 222: 611\u2013618.",
                        "@id": "25",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Combining HBV RNA and hepatitis B core-related antigen: guidance for safely stopping nucleos(t)ide analogues in HBeAg-positive chronic hepatitis B patients"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "jgh15516-cit-0026",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85083847603",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "222"},
                                "pagerange": {
                                    "@first": "611",
                                    "@last": "618"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Fan",
                                        "ce:indexed-name": "Fan R."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Peng",
                                        "ce:indexed-name": "Peng J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "Q.",
                                        "@_fa": "true",
                                        "ce:surname": "Xie",
                                        "ce:indexed-name": "Xie Q."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Infect. Dis."
                        },
                        "ce:source-text": "Fan R, Peng J, Xie Q et al. Combining HBV RNA and hepatitis B core-related antigen: guidance for safely stopping nucleos(t)ide analogues in HBeAg-positive chronic hepatitis B patients. J. Infect. Dis. 2020; 222: 611\u2013618."
                    },
                    {
                        "ref-fulltext": "Tseng TN, Hu TH, Wang JH et al. Incidence and factors associated with HBV relapse after cessation of entecavir or tenofovir in patients with HBsAg below 100 IU/mL. Clin. Gastroenterol. Hepatol. 2020; 18: 2803\u20132812.",
                        "@id": "26",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Incidence and factors associated with HBV relapse after cessation of entecavir or tenofovir in patients with HBsAg below 100 IU/mL"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "jgh15516-cit-0027",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85090204727",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "18"},
                                "pagerange": {
                                    "@first": "2803",
                                    "@last": "2812"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "T.N.",
                                        "@_fa": "true",
                                        "ce:surname": "Tseng",
                                        "ce:indexed-name": "Tseng T.N."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T.H.",
                                        "@_fa": "true",
                                        "ce:surname": "Hu",
                                        "ce:indexed-name": "Hu T.H."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.H.",
                                        "@_fa": "true",
                                        "ce:surname": "Wang",
                                        "ce:indexed-name": "Wang J.H."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin. Gastroenterol. Hepatol."
                        },
                        "ce:source-text": "Tseng TN, Hu TH, Wang JH et al. Incidence and factors associated with HBV relapse after cessation of entecavir or tenofovir in patients with HBsAg below 100 IU/mL. Clin. Gastroenterol. Hepatol. 2020; 18: 2803\u20132812."
                    },
                    {
                        "ref-fulltext": "Matsumoto ATE, Suzuki Y et al. Combination of hepatitis B viral antigens and DNA for prediction of relapse after discontinuation of nucleos(t)ide analogs in patients with chronic hepatitis B. Hepatol. Res. 2012; 42: 139\u2013149.",
                        "@id": "27",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Combination of hepatitis B viral antigens and DNA for prediction of relapse after discontinuation of nucleos(t)ide analogs in patients with chronic hepatitis B"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "jgh15516-cit-0028",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84863393007",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "42"},
                                "pagerange": {
                                    "@first": "139",
                                    "@last": "149"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.T.E.",
                                        "@_fa": "true",
                                        "ce:surname": "Matsumoto",
                                        "ce:indexed-name": "Matsumoto A.T.E."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Suzuki",
                                        "ce:indexed-name": "Suzuki Y."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Hepatol. Res."
                        },
                        "ce:source-text": "Matsumoto ATE, Suzuki Y et al. Combination of hepatitis B viral antigens and DNA for prediction of relapse after discontinuation of nucleos(t)ide analogs in patients with chronic hepatitis B. Hepatol. Res. 2012; 42: 139\u2013149."
                    },
                    {
                        "ref-fulltext": "Carey I, Gersch J, Wang B et al. Pre-genomic HBV RNA and HBcrAg predict outcomes in HBeAg negative chronic hepatitis B patients suppressed on nucleos(t)ide analogue therapy. Hepatology 2019; 72: 42\u201357.",
                        "@id": "28",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Pre-genomic HBV RNA and HBcrAg predict outcomes in HBeAg negative chronic hepatitis B patients suppressed on nucleos(t)ide analogue therapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "jgh15516-cit-0029",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85081749108",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "72"},
                                "pagerange": {
                                    "@first": "42",
                                    "@last": "57"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "I.",
                                        "@_fa": "true",
                                        "ce:surname": "Carey",
                                        "ce:indexed-name": "Carey I."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Gersch",
                                        "ce:indexed-name": "Gersch J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "B.",
                                        "@_fa": "true",
                                        "ce:surname": "Wang",
                                        "ce:indexed-name": "Wang B."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Hepatology"
                        },
                        "ce:source-text": "Carey I, Gersch J, Wang B et al. Pre-genomic HBV RNA and HBcrAg predict outcomes in HBeAg negative chronic hepatitis B patients suppressed on nucleos(t)ide analogue therapy. Hepatology 2019; 72: 42\u201357."
                    },
                    {
                        "ref-fulltext": "Papatheodoridi M, Hadziyannis E, Berby F et al. Predictors of hepatitis B surface antigen loss, relapse and retreatment after discontinuation of effective oral antiviral therapy in noncirrhotic HBeAg-negative chronic hepatitis B. J. Viral. Hepat. 2020; 27: 118\u2013126.",
                        "@id": "29",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Predictors of hepatitis B surface antigen loss, relapse and retreatment after discontinuation of effective oral antiviral therapy in noncirrhotic HBeAg-negative chronic hepatitis B"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "jgh15516-cit-0030",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85074083065",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "27"},
                                "pagerange": {
                                    "@first": "118",
                                    "@last": "126"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Papatheodoridi",
                                        "ce:indexed-name": "Papatheodoridi M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Hadziyannis",
                                        "ce:indexed-name": "Hadziyannis E."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "F.",
                                        "@_fa": "true",
                                        "ce:surname": "Berby",
                                        "ce:indexed-name": "Berby F."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Viral. Hepat."
                        },
                        "ce:source-text": "Papatheodoridi M, Hadziyannis E, Berby F et al. Predictors of hepatitis B surface antigen loss, relapse and retreatment after discontinuation of effective oral antiviral therapy in noncirrhotic HBeAg-negative chronic hepatitis B. J. Viral. Hepat. 2020; 27: 118\u2013126."
                    },
                    {
                        "ref-fulltext": "Hsu Y-C, Nguyen MH, Mo L-R et al. Combining hepatitis B core-related and surface antigens at end of nucleos(t)ide analogue treatment to predict off-therapy relapse risk. Aliment. Pharmacol. Ther. 2019; 49: 107\u2013115.",
                        "@id": "30",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Combining hepatitis B core-related and surface antigens at end of nucleos(t)ide analogue treatment to predict off-therapy relapse risk"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "jgh15516-cit-0031",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85056697891",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "49"},
                                "pagerange": {
                                    "@first": "107",
                                    "@last": "115"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "Y.-C.",
                                        "@_fa": "true",
                                        "ce:surname": "Hsu",
                                        "ce:indexed-name": "Hsu Y.-C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.H.",
                                        "@_fa": "true",
                                        "ce:surname": "Nguyen",
                                        "ce:indexed-name": "Nguyen M.H."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "L.-R.",
                                        "@_fa": "true",
                                        "ce:surname": "Mo",
                                        "ce:indexed-name": "Mo L.-R."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Aliment. Pharmacol. Ther."
                        },
                        "ce:source-text": "Hsu Y-C, Nguyen MH, Mo L-R et al. Combining hepatitis B core-related and surface antigens at end of nucleos(t)ide analogue treatment to predict off-therapy relapse risk. Aliment. Pharmacol. Ther. 2019; 49: 107\u2013115."
                    },
                    {
                        "ref-fulltext": "Wang J, Shen T, Huang X et al. Serum hepatitis B virus RNA is encapsidated pregenome RNA that may be associated with persistence of viral infection and rebound. J. Hepatol. 2016; 65: 700\u2013710.",
                        "@id": "31",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Serum hepatitis B virus RNA is encapsidated pregenome RNA that may be associated with persistence of viral infection and rebound"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "jgh15516-cit-0032",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84991619847",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "65"},
                                "pagerange": {
                                    "@first": "700",
                                    "@last": "710"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Wang",
                                        "ce:indexed-name": "Wang J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Shen",
                                        "ce:indexed-name": "Shen T."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "X.",
                                        "@_fa": "true",
                                        "ce:surname": "Huang",
                                        "ce:indexed-name": "Huang X."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Hepatol."
                        },
                        "ce:source-text": "Wang J, Shen T, Huang X et al. Serum hepatitis B virus RNA is encapsidated pregenome RNA that may be associated with persistence of viral infection and rebound. J. Hepatol. 2016; 65: 700\u2013710."
                    },
                    {
                        "ref-fulltext": "Jung KS, Park JY, Chon YE et al. Clinical outcomes and predictors for relapse after cessation of oral antiviral treatment in chronic hepatitis B patients. J. Gastroenterol. 2016; 51: 830\u2013839.",
                        "@id": "32",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Clinical outcomes and predictors for relapse after cessation of oral antiviral treatment in chronic hepatitis B patients"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "jgh15516-cit-0033",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84950274075",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "51"},
                                "pagerange": {
                                    "@first": "830",
                                    "@last": "839"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "K.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Jung",
                                        "ce:indexed-name": "Jung K.S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Park",
                                        "ce:indexed-name": "Park J.Y."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "Y.E.",
                                        "@_fa": "true",
                                        "ce:surname": "Chon",
                                        "ce:indexed-name": "Chon Y.E."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Gastroenterol."
                        },
                        "ce:source-text": "Jung KS, Park JY, Chon YE et al. Clinical outcomes and predictors for relapse after cessation of oral antiviral treatment in chronic hepatitis B patients. J. Gastroenterol. 2016; 51: 830\u2013839."
                    },
                    {
                        "ref-fulltext": "Liaw YF, Kao JH, Piratvisuth T et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update. Hepatol. Int. 2012; 6: 531\u2013561.",
                        "@id": "33",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "jgh15516-cit-0034",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84865376141",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "6"},
                                "pagerange": {
                                    "@first": "531",
                                    "@last": "561"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "Y.F.",
                                        "@_fa": "true",
                                        "ce:surname": "Liaw",
                                        "ce:indexed-name": "Liaw Y.F."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.H.",
                                        "@_fa": "true",
                                        "ce:surname": "Kao",
                                        "ce:indexed-name": "Kao J.H."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Piratvisuth",
                                        "ce:indexed-name": "Piratvisuth T."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Hepatol. Int."
                        },
                        "ce:source-text": "Liaw YF, Kao JH, Piratvisuth T et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update. Hepatol. Int. 2012; 6: 531\u2013561."
                    },
                    {
                        "ref-fulltext": "Tsuge M, Murakami E, Imamura M et al. Serum HBV RNA and HBeAg are useful markers for the safe discontinuation of nucleotide analogue treatments in chronic hepatitis B patients. J. Gastroenterol. 2013; 48: 1188\u20131204.",
                        "@id": "34",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Serum HBV RNA and HBeAg are useful markers for the safe discontinuation of nucleotide analogue treatments in chronic hepatitis B patients"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "jgh15516-cit-0035",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84892792474",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "48"},
                                "pagerange": {
                                    "@first": "1188",
                                    "@last": "1204"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Tsuge",
                                        "ce:indexed-name": "Tsuge M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Murakami",
                                        "ce:indexed-name": "Murakami E."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Imamura",
                                        "ce:indexed-name": "Imamura M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Gastroenterol."
                        },
                        "ce:source-text": "Tsuge M, Murakami E, Imamura M et al. Serum HBV RNA and HBeAg are useful markers for the safe discontinuation of nucleotide analogue treatments in chronic hepatitis B patients. J. Gastroenterol. 2013; 48: 1188\u20131204."
                    },
                    {
                        "ref-fulltext": "Gao Y, Li Y, Meng Q et al. Serum hepatitis B virus DNA, RNA, and HBsAg: which correlated better with intrahepatic covalently closed circular DNA before and after nucleos(t)ide analogue treatment? J. Clin. Microbiol. 2017; 55: 2972\u20132982.",
                        "@id": "35",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Serum hepatitis B virus DNA, RNA, and HBsAg: which correlated better with intrahepatic covalently closed circular DNA before and after nucleos(t)ide analogue treatment?"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "jgh15516-cit-0036",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85030091305",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "55"},
                                "pagerange": {
                                    "@first": "2972",
                                    "@last": "2982"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Gao",
                                        "ce:indexed-name": "Gao Y."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Li",
                                        "ce:indexed-name": "Li Y."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "Q.",
                                        "@_fa": "true",
                                        "ce:surname": "Meng",
                                        "ce:indexed-name": "Meng Q."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Clin. Microbiol."
                        },
                        "ce:source-text": "Gao Y, Li Y, Meng Q et al. Serum hepatitis B virus DNA, RNA, and HBsAg: which correlated better with intrahepatic covalently closed circular DNA before and after nucleos(t)ide analogue treatment? J. Clin. Microbiol. 2017; 55: 2972\u20132982."
                    },
                    {
                        "ref-fulltext": "Shinkai N, Tanaka Y, Orito E et al. Measurement of hepatitis B virus core-related antigen as predicting factor for relapse after cessation of lamivudine therapy for chronic hepatitis B virus infection. Hepatol. Res. 2006; 36: 272\u2013276.",
                        "@id": "36",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "Measurement of hepatitis B virus core-related antigen as predicting factor for relapse after cessation of lamivudine therapy for chronic hepatitis B virus infection"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "jgh15516-cit-0037",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "33750890637",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "36"},
                                "pagerange": {
                                    "@first": "272",
                                    "@last": "276"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "N.",
                                        "@_fa": "true",
                                        "ce:surname": "Shinkai",
                                        "ce:indexed-name": "Shinkai N."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Tanaka",
                                        "ce:indexed-name": "Tanaka Y."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Orito",
                                        "ce:indexed-name": "Orito E."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Hepatol. Res."
                        },
                        "ce:source-text": "Shinkai N, Tanaka Y, Orito E et al. Measurement of hepatitis B virus core-related antigen as predicting factor for relapse after cessation of lamivudine therapy for chronic hepatitis B virus infection. Hepatol. Res. 2006; 36: 272\u2013276."
                    },
                    {
                        "ref-fulltext": "Matsumoto A, Tanaka E, Suzuki Y et al. Combination of hepatitis B viral antigens and DNA for prediction of relapse after discontinuation of nucleos(t)ide analogs in patients with chronic hepatitis B. Hepatol. Res. 2012; 42: 139\u2013149.",
                        "@id": "37",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Combination of hepatitis B viral antigens and DNA for prediction of relapse after discontinuation of nucleos(t)ide analogs in patients with chronic hepatitis B"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "jgh15516-cit-0038",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84863393007",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "42"},
                                "pagerange": {
                                    "@first": "139",
                                    "@last": "149"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Matsumoto",
                                        "ce:indexed-name": "Matsumoto A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Tanaka",
                                        "ce:indexed-name": "Tanaka E."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Suzuki",
                                        "ce:indexed-name": "Suzuki Y."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Hepatol. Res."
                        },
                        "ce:source-text": "Matsumoto A, Tanaka E, Suzuki Y et al. Combination of hepatitis B viral antigens and DNA for prediction of relapse after discontinuation of nucleos(t)ide analogs in patients with chronic hepatitis B. Hepatol. Res. 2012; 42: 139\u2013149."
                    },
                    {
                        "ref-fulltext": "Yao C-C, Hung C-H, Hu T-H et al. Incidence and predictors of HBV relapse after cessation of nucleoside analogues in HBeAg-negative patients with HBsAg ≤ 200 IU/mL. Sci. Rep. 2017; 7: 1839.",
                        "@id": "38",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Incidence and predictors of HBV relapse after cessation of nucleoside analogues in HBeAg-negative patients with HBsAg ≤ 200 IU/mL"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "jgh15516-cit-0039",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85019225031",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "7"},
                                "pagerange": {"@first": "1839"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.-C.",
                                        "@_fa": "true",
                                        "ce:surname": "Yao",
                                        "ce:indexed-name": "Yao C.-C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C.-H.",
                                        "@_fa": "true",
                                        "ce:surname": "Hung",
                                        "ce:indexed-name": "Hung C.-H."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "T.-H.",
                                        "@_fa": "true",
                                        "ce:surname": "Hu",
                                        "ce:indexed-name": "Hu T.-H."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Sci. Rep."
                        },
                        "ce:source-text": "Yao C-C, Hung C-H, Hu T-H et al. Incidence and predictors of HBV relapse after cessation of nucleoside analogues in HBeAg-negative patients with HBsAg ≤ 200 IU/mL. Sci. Rep. 2017; 7: 1839."
                    },
                    {
                        "ref-fulltext": "Huang H, Wang J, Li W et al. Serum HBV DNA plus RNA shows superiority in reflecting the activity of intrahepatic cccDNA in treatment-naïve HBV-infected individuals. J. Clin. Virol. 2018; 99\u2013100: 71\u201378.",
                        "@id": "39",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Serum HBV DNA plus RNA shows superiority in reflecting the activity of intrahepatic cccDNA in treatment-naïve HBV-infected individuals"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "jgh15516-cit-0040",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85041358392",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "99"},
                                "pagerange": {
                                    "@first": "71",
                                    "@last": "78"
                                }
                            },
                            "ref-text": "\u2013100",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Huang",
                                        "ce:indexed-name": "Huang H."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Wang",
                                        "ce:indexed-name": "Wang J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "W.",
                                        "@_fa": "true",
                                        "ce:surname": "Li",
                                        "ce:indexed-name": "Li W."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Clin. Virol."
                        },
                        "ce:source-text": "Huang H, Wang J, Li W et al. Serum HBV DNA plus RNA shows superiority in reflecting the activity of intrahepatic cccDNA in treatment-naïve HBV-infected individuals. J. Clin. Virol. 2018; 99\u2013100: 71\u201378."
                    },
                    {
                        "ref-fulltext": "Wang L, Cao X, Wang Z et al. Correlation of HBcrAg with intrahepatic hepatitis B virus total DNA and covalently closed circular DNA in HBeAg-positive chronic hepatitis B patients. J. Clin. Microbiol. 2019; 57: e01303\u2013e01318.",
                        "@id": "40",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Correlation of HBcrAg with intrahepatic hepatitis B virus total DNA and covalently closed circular DNA in HBeAg-positive chronic hepatitis B patients"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "jgh15516-cit-0041",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85059425896",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "57"},
                                "pagerange": {
                                    "@first": "e01303",
                                    "@last": "e01318"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "L.",
                                        "@_fa": "true",
                                        "ce:surname": "Wang",
                                        "ce:indexed-name": "Wang L."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "X.",
                                        "@_fa": "true",
                                        "ce:surname": "Cao",
                                        "ce:indexed-name": "Cao X."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "Z.",
                                        "@_fa": "true",
                                        "ce:surname": "Wang",
                                        "ce:indexed-name": "Wang Z."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Clin. Microbiol."
                        },
                        "ce:source-text": "Wang L, Cao X, Wang Z et al. Correlation of HBcrAg with intrahepatic hepatitis B virus total DNA and covalently closed circular DNA in HBeAg-positive chronic hepatitis B patients. J. Clin. Microbiol. 2019; 57: e01303\u2013e01318."
                    },
                    {
                        "ref-fulltext": "Lai C-L, Wong DK-H, Wong GT-Y, Seto W-K, Fung J, Yuen M-F. Rebound of HBV DNA after cessation of nucleos/tide analogues in chronic hepatitis B patients with undetectable covalently closed. JHEP. Rep. 2020; 2: 100112 cited 01/10/2020. Available from URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242874/",
                        "@id": "41",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242874/",
                                "@type": "email"
                            }},
                            "ref-title": {"ref-titletext": "Rebound of HBV DNA after cessation of nucleos/tide analogues in chronic hepatitis B patients with undetectable covalently closed"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "jgh15516-cit-0042",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85102438246",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {"@volume": "2"}},
                            "ref-text": "cited 01/10/2020. Available from URL",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "C.-L.",
                                    "@_fa": "true",
                                    "ce:surname": "Lai",
                                    "ce:indexed-name": "Lai C.-L."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "D.K.-H.",
                                    "@_fa": "true",
                                    "ce:surname": "Wong",
                                    "ce:indexed-name": "Wong D.K.-H."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "G.T.-Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Wong",
                                    "ce:indexed-name": "Wong G.T.-Y."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "W.-K.",
                                    "@_fa": "true",
                                    "ce:surname": "Seto",
                                    "ce:indexed-name": "Seto W.-K."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Fung",
                                    "ce:indexed-name": "Fung J."
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "M.-F.",
                                    "@_fa": "true",
                                    "ce:surname": "Yuen",
                                    "ce:indexed-name": "Yuen M.-F."
                                }
                            ]},
                            "ref-sourcetitle": "JHEP. Rep."
                        },
                        "ce:source-text": "Lai C-L, Wong DK-H, Wong GT-Y, Seto W-K, Fung J, Yuen M-F. Rebound of HBV DNA after cessation of nucleos/tide analogues in chronic hepatitis B patients with undetectable covalently closed. JHEP. Rep. 2020; 2: 100112 cited 01/10/2020. Available from URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242874/"
                    },
                    {
                        "ref-fulltext": "Butler EK, Gersch J, McNamara A et al. Hepatitis B virus serum DNA andRNA levels in nucleos(t)ide analog-treated or untreated patients during chronic and acute infection. Hepatology 2018; 68: 2106\u20132117.",
                        "@id": "42",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Hepatitis B virus serum DNA andRNA levels in nucleos(t)ide analog-treated or untreated patients during chronic and acute infection"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "jgh15516-cit-0043",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85053602801",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "68"},
                                "pagerange": {
                                    "@first": "2106",
                                    "@last": "2117"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "E.K.",
                                        "@_fa": "true",
                                        "ce:surname": "Butler",
                                        "ce:indexed-name": "Butler E.K."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Gersch",
                                        "ce:indexed-name": "Gersch J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "McNamara",
                                        "ce:indexed-name": "McNamara A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Hepatology"
                        },
                        "ce:source-text": "Butler EK, Gersch J, McNamara A et al. Hepatitis B virus serum DNA andRNA levels in nucleos(t)ide analog-treated or untreated patients during chronic and acute infection. Hepatology 2018; 68: 2106\u20132117."
                    }
                ]
            }}
        }
    },
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60028190",
        "affilname": "Chulalongkorn University",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
        "affiliation-country": "Thailand"
    },
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85104272028",
        "dc:description": "Background and Aim: Hepatitis B core-related antigen (HBcrAg) and hepatitis B virus RNA (HBV RNA) are novel markers that reflect intrahepatic cccDNA and could be useful in the prediction of relapse after nucleos(t)ide analogues (NA) discontinuation. The aim of the study is to perform a systematic review on this issue. Methods: Medline/Pubmed database was searched using text terms related to HBcrAg, RNA, NAs, discontinuation, and relapse. Included studies were those that enrolled adult patients who had been on NAs for more than 6 months with available information on end-of-treatment (EOT) HBcrAg and/or HBV RNA and relapse rates. Results: Sixteen studies were included. Virological and clinical relapse rates ranged from 11% to 100% and 11% to 73%, respectively. Low or undetectable EOT HBcrAg levels were associated with low off-treatment relapse rates in most studies with area under the receiver operating characteristic curve (AUROC) of 0.69\u20130.70 for predicting virological relapse (VR) and 0.61\u20130.77 for predicting clinical relapse (CR). Undetectable EOT HBV RNA was associated with a lower risk of off-treatment relapse with AUROC of 0.65\u20130.76 for predicting VR and 0.66\u20130.73 for predicting CR. Combined EOT HBcrAg and HBV RNA performed better in predicting off-treatment relapse than either test alone with AUROC of 0.816\u20130.846 for predicting CR. None of the patients with double-negative HBV RNA and HBcrAg developed CR. Conclusion: Combining HBcrAg with HBV RNA or HBsAg improved the discriminating abilities in the prediction of off-treatment relapse of each test. Patients with double-negative HBcrAg and HBV RNA at EOT had low risks of relapse and could be considered for NA discontinuation.",
        "pubmed-id": "33811375",
        "prism:coverDate": "2021-09-01",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85104272028",
        "dc:creator": {"author": [{
            "ce:given-name": "Aunchalee",
            "preferred-name": {
                "ce:given-name": "Aunchalee",
                "ce:initials": "A.",
                "ce:surname": "Jaroenlapnopparat",
                "ce:indexed-name": "Jaroenlapnopparat A."
            },
            "@seq": "1",
            "ce:initials": "A.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Jaroenlapnopparat",
            "@auid": "57222961052",
            "author-url": "https://api.elsevier.com/content/author/author_id/57222961052",
            "ce:indexed-name": "Jaroenlapnopparat A."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85104272028"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85104272028&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85104272028&origin=inward"
            }
        ],
        "source-id": "25296",
        "citedby-count": "4",
        "prism:volume": "36",
        "subtype": "ar",
        "dc:title": "Novel viral markers and the prediction of off-treatment relapse in chronic hepatitis B patients: A systematic review",
        "openaccess": "0",
        "prism:issn": "14401746 08159319",
        "publishercopyright": "© 2021 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd",
        "prism:issueIdentifier": "9",
        "subtypeDescription": "Article",
        "prism:publicationName": "Journal of Gastroenterology and Hepatology (Australia)",
        "prism:pageRange": "2349-2362",
        "prism:endingPage": "2362",
        "openaccessFlag": "false",
        "prism:doi": "10.1111/jgh.15516",
        "prism:startingPage": "2349",
        "dc:identifier": "SCOPUS_ID:85104272028",
        "dc:publisher": "John Wiley and Sons Inc"
    },
    "idxterms": {"mainterm": [
        {
            "$": "Adult",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Biomarkers",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Hepatitis B Core Antigens",
            "@weight": "a",
            "@candidate": "n"
        },
        {
            "$": "Hepatitis B virus",
            "@weight": "a",
            "@candidate": "n"
        },
        {
            "$": "Hepatitis B, Chronic",
            "@weight": "a",
            "@candidate": "n"
        },
        {
            "$": "Humans",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Recurrence",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "RNA, Viral",
            "@weight": "a",
            "@candidate": "n"
        }
    ]},
    "language": {"@xml:lang": "eng"},
    "authkeywords": {"author-keyword": [
        {
            "@_fa": "true",
            "$": "Chronic hepatitis B"
        },
        {
            "@_fa": "true",
            "$": "Hepatitis B core-related antigen"
        },
        {
            "@_fa": "true",
            "$": "Hepatitis B virus RNA"
        },
        {
            "@_fa": "true",
            "$": "Nucleos(t)ide analogues"
        },
        {
            "@_fa": "true",
            "$": "Relapse"
        }
    ]},
    "subject-areas": {"subject-area": [
        {
            "@_fa": "true",
            "$": "Hepatology",
            "@code": "2721",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Gastroenterology",
            "@code": "2715",
            "@abbrev": "MEDI"
        }
    ]},
    "authors": {"author": [
        {
            "ce:given-name": "Aunchalee",
            "preferred-name": {
                "ce:given-name": "Aunchalee",
                "ce:initials": "A.",
                "ce:surname": "Jaroenlapnopparat",
                "ce:indexed-name": "Jaroenlapnopparat A."
            },
            "@seq": "1",
            "ce:initials": "A.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Jaroenlapnopparat",
            "@auid": "57222961052",
            "author-url": "https://api.elsevier.com/content/author/author_id/57222961052",
            "ce:indexed-name": "Jaroenlapnopparat A."
        },
        {
            "ce:given-name": "Maneerat",
            "preferred-name": {
                "ce:given-name": "Maneerat",
                "ce:initials": "M.",
                "ce:surname": "Chayanupatkul",
                "ce:indexed-name": "Chayanupatkul M."
            },
            "@seq": "2",
            "ce:initials": "M.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Chayanupatkul",
            "@auid": "26031971600",
            "author-url": "https://api.elsevier.com/content/author/author_id/26031971600",
            "ce:indexed-name": "Chayanupatkul M."
        },
        {
            "ce:given-name": "Pisit",
            "preferred-name": {
                "ce:given-name": "Pisit",
                "ce:initials": "P.",
                "ce:surname": "Tangkijvanich",
                "ce:indexed-name": "Tangkijvanich P."
            },
            "@seq": "3",
            "ce:initials": "P.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Tangkijvanich",
            "@auid": "7003646635",
            "author-url": "https://api.elsevier.com/content/author/author_id/7003646635",
            "ce:indexed-name": "Tangkijvanich P."
        }
    ]}
}}